Alterations of the Intestinal Barrier in Patients With Autism Spectrum Disorders and in Their First‐degree Relatives
The DOI matches its Crossref record; 54 of the 55 references it cites were found in a registry or an index.
Abstract
Objectives Intestinal permeability (IPT) was investigated in patients with autism as well as in their first-degree relatives to investigate leaky gut hypothesis. Faecal calprotectin (FC) was also measured in patients with autism, either with or without gastrointestinal symptoms, and in their first-degree relatives. Patients and methods IPT results, assessed by means of the lactulose/mannitol test, were compared with adult and child controls and with FC values. Results A high percentage of abnormal IPT values were found among patients with autism (36.7%) and their relatives (21.2%) compared with normal subjects (4.8%). Patients with autism on a reported gluten-casein-free diet had significantly lower IPT values compared with those who were on an unrestricted diet and controls. Gastrointestinal symptoms were present in 46.7% of children with autism: constipation (45.5%), diarrhoea (34.1%), and others (alternating diarrhoea/constipation, abdominal pain, etc: 15.9%). FC was elevated in 24.4% of patients with autism and in 11.6% of their relatives; it was not, however, correlated with abnormal IPT values. Conclusions The results obtained support the leaky gut hypothesis and indicate that measuring IPT could help to identify a subgroup of patients with autism who could benefit from a gluten-free diet. The IPT alterations found in first-degree relatives suggest the presence of an intestinal (tight-junction linked) hereditary factor in the families of subjects with autism.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Offspring from the poly (I:C) mouse model of MIA exhibit gastrointestinal changes that are also found in some humans with ASD155,156, including increased intestinal permeability and abnormal intestinal cytokine profiles157.”
From Immune mediators in the brain and peripheral tissues in autism spectrum disorder (2015) · cites this paper as [156]
In the citing paper
“In the case of impaired BBB, which can be observed in certain (but not all) autistic subjects [37,254], LPS or SCFAs may cause brain inflammation and thus, further facilitate access to the brain for harmful substances, like heavy metals, that can accumulate there [228,246,255].”
From The Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders (2021) · cites this paper as [254]
In the citing paper
“Along with altered bowel habits, ASD has been associated with impaired intestinal barrier function (D'Eufemia et al., 1996; de Magistris et al., 2010; Fiorentino et al., 2016).”
From Microbiota-related Changes in Bile Acid & Tryptophan Metabolism are Associated with Gastrointestinal Dysfunction in a Mouse Model of Autism (2017) · cites this paper as de Magistris et al., 2010
In the citing paper
“Many ASD children have also been shown to carry abnormalities in GI physiology, including: increased intestinal permeability [34,35], overall microbiota alterations [36,37,38,39,40], and gut infection with cresol-producing Clostridium difficile [39,41,42,43,44].”
From Autism, Gastrointestinal Symptoms and Modulation of Gut Microbiota by Nutritional Interventions (2019) · cites this paper as [35]
In the citing paper
“Intestinal dysbiosis is often associated, in the ASD population, with an alteration of the barrier of the intestinal mucosa with consequent increase of the intestinal permeability to exogenous substances of alimentary or bacterial origin, in some cases even neurotoxic [35].”
From Autism, Gastrointestinal Symptoms and Modulation of Gut Microbiota by Nutritional Interventions (2019) · cites this paper as [35]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
2 retracted
Gluten- and casein-free diets for autistic spectrum disorder
Millward, C., Ferriter, M., Calver, S. J., & Connell-Jones, G. G. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003498.pub3 · Cited by 274
RetractedGluten- and casein-free diets for autistic spectrum disorder
Ferriter, M., Calver, S. J., Connell-Jones, G. G., & Millward, C. (2001) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003498 · Cited by 27
RetractedLord, C., Rutter, M., & Le Couteur, A. (1994) · Journal of Autism and Developmental Disorders · doi:10.1007/bf02172145 · Cited by 9,065 · cited 1×
“All of the children were administered the Autism Diagnostic Interview-Revised version (23), the Childhood Autism Rating Scales (24), and the Autism Diagnostic Observation Schedule-Generic (25) to document the diagnosis of autism.”
MethodToward objective classification of childhood autism: Childhood Autism Rating Scale (CARS)
Schopler, E., Reichler, R. J., DeVellis, R. F., & Daly, K. (1980) · Journal of Autism and Developmental Disorders · doi:10.1007/bf02408436 · Cited by 2,432 · cited 1×
“All of the children were administered the Autism Diagnostic Interview-Revised version (23), the Childhood Autism Rating Scales (24), and the Autism Diagnostic Observation Schedule-Generic (25) to document the diagnosis of autism.”
MethodIntestinal permeability: an overview
Bjarnason, I., Macpherson, A., & Hollander, D. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90708-4 · Cited by 927 · cited 2×
“IPT, as measured by the urinary excretion of metabolically inert sugars after oral dosing, is a surrogate marker of mucosal integrity (16) and of gut barrier function.”
BackgroundBuie, T., Campbell, D. B., Fuchs, G. J., Furuta, G. T., Levy, J., VandeWater, J., Whitaker, A. H., Atkins, D., Bauman, M. L., Beaudet, A. L., et al. (2010) · Pediatrics · doi:10.1542/peds.2009-1878c · Cited by 872 · cited 2×
“The precise role or frequency of increased paracellular permeability in children with ASD, as well as its correlation with the various clinical and behavioural aspects of ASD, remain unclear (5).”
BackgroundAssessment of the Neutrophil Dominating Protein Calprotectin in Feces: A Methodologic Study
RØseth, A. G., Fagerhol, M. K., Aadland, E., & Schjønsby, H. (1992) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529209011186 · Cited by 669 · cited 1×
“Normal values were estimated to be <100 mg/g stool (adult and children) on the basis of previous reports (28,29) and our own laboratory experience.”
BackgroundLammers, K. M., Lu, R., Brownley, J., Lu, B., Gerard, C., Thomas, K., Rallabhandi, P., Shea-Donohue, T., Tamiz, A., Alkan, S., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.023 · Cited by 540 · cited 1×
“The influence of environment (ie, ‘‘toxic’’ gluten) (35,51) on the intestinal barrier is also suggested.”
BackgroundIdentification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2
Tripathi, A., Lammers, K. M., Goldblum, S., Shea-Donohue, T., Netzel-Arnett, S., Buzza, M. S., Antalis, T. M., Vogel, S. N., Zhao, A., Yang, S., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906773106 · Cited by 443 · cited 1×
“The influence of environment (ie, ‘‘toxic’’ gluten) (35,51) on the intestinal barrier is also suggested.”
BackgroundTibble, J. A., Sigthorsson, G., Foster, R., Forgacs, I., & Bjarnason, I. (2002) · Gastroenterology · doi:10.1053/gast.2002.34755 · Cited by 441 · cited 1×
“Even though the possibility of day-to-day FC variations exists (48), our findings are in keeping with previous reports (49) and do not confirm those by Tibble et al (50).”
Result
Research works printed but not linked: 2
- Turck D, 2008, Walker's Pediatric Gastroenterologic Diseases: Pathophysiology, Diagnosis, Management
- 10.1097/00005176-200107000-00003 · doi:10.1097/00005176-200107000-00003 · Paper page
Cited by
Hsiao, E. Y., McBride, S. W., Hsien, S., Sharon, G., Hyde, E. R., McCue, T., Codelli, J. A., Chow, J., Reisman, S. E., Petrosino, J. F., et al. (2013) · Cell · doi:10.1016/j.cell.2013.11.024 · Cited by 3,283
“We utilize the maternal immune activation (MIA) model, which is based on large epidemiological studies linking maternal infection to increased autism risk in the offspring (Atladó ttir et al., 2010; Gorrindo et al., 2012).”
The Oslo definitions for coeliac disease and related terms
Ludvigsson, J. F., Leffler, D. A., Bai, J. C., Biagi, F., Fasano, A., Green, P. H. R., Hadjivassiliou, M., Kaukinen, K., Kelly, C. P., Leonard, J. N., et al. (2013) · Gut · doi:10.1136/gutjnl-2011-301346 · Cited by 1,721
The intestinal barrier: a fundamental role in health and disease
Vancamelbeke, M., & Vermeire, S. (2017) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2017.1343143 · Cited by 1,287
“with abnormal intestinal permeability values [43,44].”
Spectrum of gluten-related disorders: consensus on new nomenclature and classification
Sapone, A., Bai, J. C., Ciacci, C., Dolinsek, J., Green, P. H., Hadjivassiliou, M., Kaukinen, K., Rostami, K., Sanders, D. S., Schumann, M., et al. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-13 · Cited by 1,140
“Through the years, a GFD has been experimentally applied to schizophrenia, multiple sclerosis, ASD and dementia, to name only a few instances.”
BackgroundSelf-citationKelly, J. R., Kennedy, P. J., Cryan, J. F., Dinan, T. G., Clarke, G., & Hyland, N. P. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00392 · Cited by 1,110
“…permeability Preclinical Moussaoui et al., 2014 FECAL MARKERS Calprotectin Feces Nonspecific marker of gut inflammation Clinical and preclinical de Magistris et al., 2010 Zonulin Feces Marker of intestinal permeability Clinical Lamprecht et al., 2012 EX VIVO Ussing chamber Ex vivo biopsies…”
BackgroundAdams, J. B., Johansen, L. J., Powell, L. D., Quig, D., & Rubin, R. A. (2011) · BMC Gastroenterology · doi:10.1186/1471-230x-11-22 · Cited by 1,076
The Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders
Socała, K., Doboszewska, U., Szopa, A., Serefko, A., Włodarczyk, M., Zielińska, A., Poleszak, E., Fichna, J., & Wlaź, P. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105840 · Cited by 857
Chelakkot, C., Choi, Y., Kim, D.-K., Park, H. T., Ghim, J., Kwon, Y., Jeon, J., Kim, M.-S., Jee, Y.-K., Gho, Y. S., et al. (2018) · Experimental & Molecular Medicine · doi:10.1038/emm.2017.282 · Cited by 840
Human Intestinal Barrier Function in Health and Disease
König, J., Wells, J., Cani, P. D., García-Ródenas, C. L., MacDonald, T., Mercenier, A., Whyte, J., Troost, F., & Brummer, R.-J. (2016) · Clinical and Translational Gastroenterology · doi:10.1038/ctg.2016.54 · Cited by 780
“An increased intestinal permeability in children with autism spectrum disorder as well as their first-degree relatives could be shown in one study.(167) Also in depression, a disturbed intestinal barrier seems to a have a role.”
BackgroundParacellular permeability and tight junction regulation in gut health and disease
Horowitz, A., Chanez-Paredes, S. D., Haest, X., & Turner, J. R. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00766-3 · Cited by 687
Tlaskalová-Hogenová, H., Štěpánková, R., Kozáková, H., Hudcovic, T., Vannucci, L., Tučková, L., Rossmann, P., Hrnčíř, T., Kverka, M., Zákostelská, Z., et al. (2011) · Cellular & Molecular Immunology · doi:10.1038/cmi.2010.67 · Cited by 693
Mouries, J., Brescia, P., Silvestri, A., Spadoni, I., Sorribas, M., Wiest, R., Mileti, E., Galbiati, M., Invernizzi, P., Adorini, L., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.08.005 · Cited by 688
Gastrointestinal microbiota in children with autism in Slovakia
Tomova, A., Husarova, V., Lakatosova, S., Bakos, J., Vlkova, B., Babinska, K., & Ostatnikova, D. (2015) · Physiology & Behavior · doi:10.1016/j.physbeh.2014.10.033 · Cited by 632
The bowel and beyond: The enteric nervous system in neurological disorders
Rao, M., & Gershon, M. D. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.107 · Cited by 629
Emerging Roles for the Gut Microbiome in Autism Spectrum Disorder
Vuong, H. E., & Hsiao, E. Y. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.08.024 · Cited by 595
Diagnosis of Non-Celiac Gluten Sensitivity (NCGS): The Salerno Experts’ Criteria
Catassi, C., Elli, L., Bonaz, B., Bouma, G., Carroccio, A., Castillejo, G., Cellier, C., Cristofori, F., De Magistris, L., Dolinsek, J., et al. (2015) · Nutrients · doi:10.3390/nu7064966 · Cited by 568
“, the brain-gut axis) postulates the existence of an increased intestinal permeability, also referred to as the “leaky gut syndrome” [15].”
BackgroundSelf-citationImmune mediators in the brain and peripheral tissues in autism spectrum disorder
Estes, M. L., & McAllister, A. K. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3978 · Cited by 514
Maternal infection and immune involvement in autism
Patterson, P. H. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.03.001 · Cited by 520
“These inflammatory changes are associated with autoimmune responses that could contribute to the observations of decreased mucosal integrity, or “leaky gut” (16).”
BackgroundBlood–brain barrier and intestinal epithelial barrier alterations in autism spectrum disorders
Fiorentino, M., Sapone, A., Senger, S., Camhi, S. S., Kadzielski, S. M., Buie, T. M., Kelly, D. L., Cascella, N., & Fasano, A. (2016) · Molecular Autism · doi:10.1186/s13229-016-0110-z · Cited by 494
Self-citationNon-Celiac Gluten Sensitivity: The New Frontier of Gluten Related Disorders
Catassi, C., Bai, J., Bonaz, B., Bouma, G., Calabrò, A., Carroccio, A., Castillejo, G., Ciacci, C., Cristofori, F., Dolinsek, J., et al. (2013) · Nutrients · doi:10.3390/nu5103839 · Cited by 492
“Patients with autism on a reported GFCF diet had significantly lower intestinal permeability test values compared with those who were on an unrestricted diet and controls [24].”
BackgroundSelf-citationAutism Spectrum Disorders and the Gut Microbiota
Fattorusso, A., Di Genova, L., Dell’Isola, G., Mencaroni, E., & Esposito, S. (2019) · Nutrients · doi:10.3390/nu11030521 · Cited by 484
“However, other studies have not found an increase in faecal calprotectin, lactoferrin, secretory IgA or elastase in ASD patients compared to typical children [44,53,83].”
BackgroundInfluentialThe Gut Microbiota and Autism Spectrum Disorders
Li, Q., Han, Y., Dy, A. B. C., & Hagerman, R. J. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00120 · Cited by 462
“…sulfate; 5-HT, serotonin; HPA, hypothalamic–pituitary–adrenal; SCFAs, short-chain fatty acids; BBB, blood-brain barrier; 5-HT, 5-hydroxytryptamine; ENS, enteric nervous system; GABA, γ-aminobutyric acid; DA, dopamine. children compared with healthy controls (de Magistris et al., 2010).”
BackgroundImmunoneuropsychiatry — novel perspectives on brain disorders
Pape, K., Tamouza, R., Leboyer, M., & Zipp, F. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0174-4 · Cited by 458
Sapone, A., Lammers, K. M., Casolaro, V., Cammarota, M., Giuliano, M. T., De Rosa, M., Stefanile, R., Mazzarella, G., Tolone, C., Russo, M. I., et al. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-23 · Cited by 452
“Similarly, higher than expected titers of AGAs, signs and symptoms associated with non-CD gluten sensitivity, have also been reported for schizophrenia [39] and autism spectrum disorders [40].”
BackgroundSelf-citationAltered gut microbiota and activity in a murine model of autism spectrum disorders
de Theije, C. G. M., Wopereis, H., Ramadan, M., van Eijndthoven, T., Lambert, J., Knol, J., Garssen, J., Kraneveld, A. D., & Oozeer, R. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2013.12.005 · Cited by 433
Wang, L., Christophersen, C. T., Sorich, M. J., Gerber, J. P., Angley, M. T., & Conlon, M. A. (2011) · Applied and Environmental Microbiology · doi:10.1128/aem.05212-11 · Cited by 432
“A previous study (6) has indicated that there may be increased gut permeability in ASD children and their first-degree relatives.”
BackgroundWang, L., Christophersen, C. T., Sorich, M. J., Gerber, J. P., Angley, M. T., & Conlon, M. A. (2013) · Molecular Autism · doi:10.1186/2040-2392-4-42 · Cited by 418
“Indeed, increased gut permeability has been reported in a subgroup of children with ASD [18,19].”
BackgroundFecal Microbiota Transplantation in Neurological Disorders
Vendrik, K. E. W., Ooijevaar, R. E., de Jong, P. R. C., Laman, J. D., van Oosten, B. W., van Hilten, J. J., Ducarmon, Q. R., Keller, J. J., Kuijper, E. J., & Contarino, M. F. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00098 · Cited by 413
Wang, L., Christophersen, C. T., Sorich, M. J., Gerber, J. P., Angley, M. T., & Conlon, M. A. (2012) · Digestive Diseases and Sciences · doi:10.1007/s10620-012-2167-7 · Cited by 412
“Increased intestinal permeability has been reported in ASD [21, 22] and this could be related to changes in fecal production of acetic acid or other SCFA.”
BackgroundThe influence of neuroinflammation in Autism Spectrum Disorder
Matta, S. M., Hill-Yardin, E. L., & Crack, P. J. (2019) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2019.04.037 · Cited by 416
Role of microbiota-derived short-chain fatty acids in nervous system disorders
Mirzaei, R., Bouzari, B., Hosseini-Fard, S. R., Mazaheri, M., Ahmadyousefi, Y., Abdi, M., Jalalifar, S., Karimitabar, Z., Teimoori, A., Keyvani, H., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111661 · Cited by 386
Differences in fecal microbial metabolites and microbiota of children with autism spectrum disorders
Kang, D.-W., Ilhan, Z. E., Isern, N. G., Hoyt, D. W., Howsmon, D. P., Shaffer, M., Lozupone, C. A., Hahn, J., Adams, J. B., & Krajmalnik-Brown, R. (2018) · Anaerobe · doi:10.1016/j.anaerobe.2017.12.007 · Cited by 381
“Given that children with ASD have abnormal intestinal permeabi lity [82, 83], lower relative abundances of F.”
BackgroundWilliams, B. L., Hornig, M., Parekh, T., & Lipkin, W. I. (2012) · mBio · doi:10.1128/mbio.00261-11 · Cited by 378
Intestinal Permeability Defects: Is It Time to Treat?
Odenwald, M. A., & Turner, J. R. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.07.001 · Cited by 366
Golubeva, A. V., Joyce, S. A., Moloney, G., Burokas, A., Sherwin, E., Arboleya, S., Flynn, I., Khochanskiy, D., Moya-Pérez, A., Peterson, V., et al. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.09.020 · Cited by 364
“D Along with altered bowel habits, ASD has been associated with impaired intestinal barrier function (D'Eufemia et al., 1996; de Magistris et al., 2010; Fiorentino et al., 2016).”
Autism spectrum disorders and intestinal microbiota
De Angelis, M., Francavilla, R., Piccolo, M., De Giacomo, A., & Gobbetti, M. (2015) · Gut Microbes · doi:10.1080/19490976.2015.1035855 · Cited by 311
Self-citationMorris, G., Berk, M., Carvalho, A., Caso, J. R., Sanz, Y., Walder, K., & Maes, M. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-0004-2 · Cited by 307
Microbiota regulation of the mammalian gut-brain axis
Burokas, A., Moloney, R. D., Dinan, T. G., & Cryan, J. F. (2015) · Advances in applied microbiology · doi:10.1016/bs.aambs.2015.02.001 · Cited by 300
Inflammation and Neuro-Immune Dysregulations in Autism Spectrum Disorders
Siniscalco, D., Schultz, S., Brigida, A. L., & Antonucci, N. (2018) · Pharmaceuticals · doi:10.3390/ph11020056 · Cited by 293
“Calprotectin was used as non-invasive marker to assess intestinal inflammation [32].”
MethodThe digestive neuronal–glial–epithelial unit: a new actor in gut health and disease
Neunlist, M., Van Landeghem, L., Mahé, M. M., Derkinderen, P., des Varannes, S. B., & Rolli-Derkinderen, M. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.221 · Cited by 278
Exploring Bacteroidetes: Metabolic key points and immunological tricks of our gut commensals
Gibiino, G., Lopetuso, L. R., Scaldaferri, F., Rizzatti, G., Binda, C., & Gasbarrini, A. (2018) · Digestive and Liver Disease · doi:10.1016/j.dld.2018.03.016 · Cited by 278
Ketogenic diet modifies the gut microbiota in a murine model of autism spectrum disorder
Newell, C., Bomhof, M. R., Reimer, R. A., Hittel, D. S., Rho, J. M., & Shearer, J. (2016) · Molecular Autism · doi:10.1186/s13229-016-0099-3 · Cited by 272
Gastrointestinal Conditions in Children With Autism Spectrum Disorder: Developing a Research Agenda
Coury, D. L., Ashwood, P., Fasano, A., Fuchs, G., Geraghty, M., Kaul, A., Mawe, G., Patterson, P., & Jones, N. E. (2012) · Pediatrics · doi:10.1542/peds.2012-0900n · Cited by 264
Gut Microbiota Features in Young Children With Autism Spectrum Disorders
Coretti, L., Paparo, L., Riccio, M. P., Amato, F., Cuomo, M., Natale, A., Borrelli, L., Corrado, G., De Caro, C., Comegna, M., et al. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.03146 · Cited by 266
Self-citationAutism: the micro-movement perspective
Torres, E. B., Brincker, M., Isenhower, R. W., Yanovich, P., Stigler, K. A., Nurnberger, J. I., Metaxas, D. N., & José, J. V. (2013) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2013.00032 · Cited by 257
“These involve the enteric (gastro-intestinal) subsystems (Ashwood et al., 2003; Molloy and Manning-Courtney, 2003; Buie et al., 2010; de Magistris et al., 2010; Kushak et al., 2011; MacFabe et al., 2011; Mazurek et al., 2013) as well as issues with the circadian rhythms (Bourgeron, 2007; Glickman,…”
BackgroundSanctuary, M. R., Kain, J. N., Chen, S. Y., Kalanetra, K., Lemay, D. G., Rose, D. R., Yang, H. T., Tancredi, D. J., German, J. B., Slupsky, C. M., et al. (2019) · PLOS ONE · doi:10.1371/journal.pone.0210064 · Cited by 255
Severance, E. G., Yolken, R. H., & Eaton, W. W. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2014.06.027 · Cited by 253
“Interestingly, autistic patients on casein-free and gluten-free diets compared to those who received unrestricted diets generally show less immune-associated infiltration and intestinal permeability (Ashwood et al., 2003; Ashwood et al., 2004; de Magistris et al., 2010).”
BackgroundImmune Dysfunction and Autoimmunity as Pathological Mechanisms in Autism Spectrum Disorders
Hughes, H. K., Mills Ko, E., Rose, D., & Ashwood, P. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00405 · Cited by 245
Metabolic Perturbance in Autism Spectrum Disorders: A Metabolomics Study
Ming, X., Stein, T. P., Barnes, V., Rhodes, N., & Guo, L. (2012) · Journal of Proteome Research · doi:10.1021/pr300910n · Cited by 234
Gut microbiota and autism: key concepts and findings
Ding, H. T., Taur, Y., & Walkup, J. T. (2017) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-016-2960-9 · Cited by 232
Rose, D. R., Yang, H., Serena, G., Sturgeon, C., Ma, B., Careaga, M., Hughes, H. K., Angkustsiri, K., Rose, M., Hertz-Picciotto, I., et al. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.03.025 · Cited by 227
The “psychomicrobiotic”: targeting microbiota in major psychiatric disorders: a systematic review
Fond, G., Boukouaci, W., Chevalier, G., Regnault, A., Eberl, G., Hamdani, N., Dickerson, F., Macgregor, A., Boyer, L., Dargel, A., et al. (2015) · Pathologie Biologie · doi:10.1016/j.patbio.2014.10.003 · Cited by 219
Interactions of innate and adaptive immunity in brain development and function
Filiano, A. J., Gadani, S. P., & Kipnis, J. (2015) · Brain Research · doi:10.1016/j.brainres.2014.07.050 · Cited by 214
“…comprehensive review of studies linking familial autoimmune disorders and ASD (McDougle et al., 2014)) and evidence of increased gut permeability and gastrointestinal disorders in ASD patients (Buie et al., 2010, de Magistris et al., 2010, Kohane et al., 2012, Hsiao, 2014, McElhanon et al., 2014).”
BackgroundSantocchi, E., Guiducci, L., Fulceri, F., Billeci, L., Buzzigoli, E., Apicella, F., Calderoni, S., Grossi, E., Morales, M. A., & Muratori, F. (2016) · BMC Psychiatry · doi:10.1186/s12888-016-0887-5 · Cited by 213
Autism, Gastrointestinal Symptoms and Modulation of Gut Microbiota by Nutritional Interventions
Ristori, M. V., Quagliariello, A., Reddel, S., Ianiro, G., Vicari, S., Gasbarrini, A., & Putignani, L. (2019) · Nutrients · doi:10.3390/nu11112812 · Cited by 214
“Intestinal dysbiosis is often associated, in the ASD population, with an alteration of the barrier of the intestinal mucosa with consequent increase of the intestinal permeability to exogenous substances of alimentary or bacterial origin, in some cases even neurotoxic [35].”
BackgroundGastrointestinal issues in autism spectrum disorder
Hsiao, E. Y. (2014) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000029 · Cited by 209
Neurologic and Psychiatric Manifestations of Celiac Disease and Gluten Sensitivity
Jackson, J. R., Eaton, W. W., Cascella, N. G., Fasano, A., & Kelly, D. L. (2012) · Psychiatric Quarterly · doi:10.1007/s11126-011-9186-y · Cited by 207
“Patients with ASD who have been treated with gluten- and caseinfree diet have been found to have better intestinal permeability when compared to patients on an unrestricted diet [46].”
BackgroundEmerging biomarkers in autism spectrum disorder: a systematic review
Frye, R. E., Vassall, S., Kaur, G., Lewis, C., Karim, M., & Rossignol, D. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.11.53 · Cited by 206
Organ-specific protection mediated by cooperation between vascular and epithelial barriers
Spadoni, I., Fornasa, G., & Rescigno, M. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.100 · Cited by 202
de Theije, C. G. M., Wu, J., da Silva, S. L., Kamphuis, P. J., Garssen, J., Korte, S. M., & Kraneveld, A. D. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.07.013 · Cited by 202
“Recently, de Magistris et al. (2010) confirmed these findings by demonstrating significantly increased intestinal permeability in children with ASD and their first-degree relatives (de Magistris et al.”
Changes in the Gut Microbiota of Children with Autism Spectrum Disorder
Zou, R., Xu, F., Wang, Y., Duan, M., Guo, M., Zhang, Q., Zhao, H., & Zheng, H. (2020) · Autism Research · doi:10.1002/aur.2358 · Cited by 198
“The lower abundance of A. muciniphila in samples from children with ASD suggests abnormally elevated gut permeability in ASD children, which is consistent with the results of a previous study [de Magistris et al., 2010].”
ResultSantocchi, E., Guiducci, L., Prosperi, M., Calderoni, S., Gaggini, M., Apicella, F., Tancredi, R., Billeci, L., Mastromarino, P., Grossi, E., et al. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.550593 · Cited by 198
“alterations in circulating cytokine levels (17) and in fecal calprotectin levels (18, 19)].”
BackgroundZhang, M., Ma, W., Zhang, J., He, Y., & Wang, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-32219-2 · Cited by 188
Urinary p-cresol in autism spectrum disorder
Persico, A. M., & Napolioni, V. (2013) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2012.09.002 · Cited by 189
Intestinal Dysbiosis and Yeast Isolation in Stool of Subjects with Autism Spectrum Disorders
Iovene, M. R., Bombace, F., Maresca, R., Sapone, A., Iardino, P., Picardi, A., Marotta, R., Schiraldi, C., Siniscalco, D., Serra, N., et al. (2017) · Mycopathologia · doi:10.1007/s11046-016-0068-6 · Cited by 184
Self-citationJolanta Wasilewska, J., & Klukowski, M. (2015) · Pediatric Health, Medicine and Therapeutics · doi:10.2147/phmt.s85717 · Cited by 182
“Hypothesis of intestinal barrier integrity impairment Leaky gut syndrome as a sign of enteropathy in children with ASD has been discussed by many and confirmed by some authors.(77) The intestinal barrier is multi-structured and involved in epithelial cell integrity, epithelial transcellular and paracellular permeabili…”
BackgroundEsteban-Figuerola, P., Canals, J., Fernández-Cao, J. C., & Arija Val, V. (2019) · Autism · doi:10.1177/1362361318794179 · Cited by 181
“Children with ASD might have higher intestinal permeability (De Magistris et al., 2010) and an alteration in the dipeptidyl peptidase IV enzyme (DPPIV), which is involved in β-casomorphin-7 metabolism (Reichelt et al., 1991).”
BackgroundCoretti, L., Cristiano, C., Florio, E., Scala, G., Lama, A., Keller, S., Cuomo, M., Russo, R., Pero, R., Paciello, O., et al. (2017) · Scientific Reports · doi:10.1038/srep45356 · Cited by 175
Microbiota-gut brain axis involvement in neuropsychiatric disorders
Iannone, L. F., Preda, A., Blottière, H. M., Clarke, G., Albani, D., Belcastro, V., Carotenuto, M., Cattaneo, A., Citraro, R., Ferraris, C., et al. (2019) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2019.1638763 · Cited by 177
“the intestinal permeability seems to be increased [101].”
BackgroundThe epithelial barrier theory and its associated diseases
Sun, N., Ogulur, I., Mitamura, Y., Yazici, D., Pat, Y., Bu, X., Li, M., Zhu, X., Babayev, H., Ardicli, S., et al. (2024) · Allergy · doi:10.1111/all.16318 · Cited by 173
The Potential Role of Probiotics in the Management of Childhood Autism Spectrum Disorders
Critchfield, J. W., van Hemert, S., Ash, M., Mulder, L., & Ashwood, P. (2011) · Gastroenterology Research and Practice · doi:10.1155/2011/161358 · Cited by 174
“[46] L.”
BackgroundBojović, K., Ignjatović, Ð. D. I., Soković Bajić, S., Vojnović Milutinović, D., Tomić, M., Golić, N., & Tolinački, M. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00223 · Cited by 171
Plasma metabolomic profiles enhance precision medicine for volunteers of normal health
Guo, L., Milburn, M. V., Ryals, J. A., Lonergan, S. C., Mitchell, M. W., Wulff, J. E., Alexander, D. C., Evans, A. M., Bridgewater, B., Miller, L., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1508425112 · Cited by 170
Microglia and Neurodevelopmental Disorders
Lukens, J. R., & Eyo, U. B. (2022) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-110920-023056 · Cited by 169
The contribution of the gut microbiome to neurodevelopment and neuropsychiatric disorders
Warner, B. B. (2019) · Pediatric Research · doi:10.1038/s41390-018-0191-9 · Cited by 168
Gut microbiota: a potential regulator of neurodevelopment
Tognini, P. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00025 · Cited by 163
“…(ASD) patients exhibit GI symptoms, abdominal pain, increased intestinal permeability (Valicenti-McDermott et al., 2006; Boukthir et al., 2010; de Magistris et al., 2010; Coury et al., 2012; Hsiao, 2014) and, intriguingly, an altered composition of their gut microbiome (Kohane et al., 2012; Kang…”
BackgroundAutism Spectrum Disorders: Etiology and Pathology
Sauer, A. K., Stanton, J. E., Hans, S., & Grabrucker, A. M. (2021) · Exon Publications eBooks · doi:10.36255/exonpublications.autismspectrumdisorders.2021.etiology · Cited by 276
Urinary p-cresol is elevated in small children with severe autism spectrum disorder
Altieri, L., Neri, C., Sacco, R., Curatolo, P., Benvenuto, A., Muratori, F., Santocchi, E., Bravaccio, C., Lenti, C., Saccani, M., et al. (2011) · Biomarkers · doi:10.3109/1354750x.2010.548010 · Cited by 161
“Nonetheless, at least some studies document abnormally elevated ratios of urinary lactulose/mannitol following a standardized oral isomolar load of these © 2011 Informa UK, Ltd. two probes (D’Eufemia et al., 1996; de Magistris et al., 2010).”
BackgroundSelf-citationAssociation of Food Allergy and Other Allergic Conditions with Autism Spectrum Disorder in Children
Xu, G., Snetselaar, L. G., Jing, J., Liu, B., Strathearn, L., & Bao, W. (2018) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.0279 · Cited by 159
Can probiotics benefit children with autism spectrum disorders?
Navarro, F., Liu, Y., & Rhoads, J. M. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i46.10093 · Cited by 154
Kral, T. V. E., Eriksen, W. T., Souders, M. C., & Pinto-Martin, J. A. (2013) · Journal of Pediatric Nursing · doi:10.1016/j.pedn.2013.01.008 · Cited by 153
Increased Serum Zonulin Levels as an Intestinal Permeability Marker in Autistic Subjects
Esnafoğlu, E., Cırrık, S., Ayyıldız, S. N., Erdil, A., Ertürk, E. Y., Dağlı, A., & Noyan, T. (2017) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2017.04.004 · Cited by 170
“See editorial, p 15 E pidemiologic studies estimate that the incidence of autism spectrum disorders (ASDs) is increasing and it affects nearly1% of the population.1,2 To date, despite a considerable amount of research, the etiology and pathophysiology of ASDremain poorly understood.3 Children with ASD have a high rate…”
BackgroundResultInfluentialMicrobes and the mind: emerging hallmarks of the gut microbiota-brain axis
Bauer, K. C., Huus, K. E., & Finlay, B. B. (2016) · Cellular Microbiology · doi:10.1111/cmi.12585 · Cited by 151
“Moreover, the symptoms of ASD could be recapitulated with a microbially produced metabolite (Hsiao et al., 2013).”
BackgroundInfluentialHarvey, L., & Boksa, P. (2012) · Developmental Neurobiology · doi:10.1002/dneu.22043 · Cited by 165
“…infection may be a risk factor for both inflammatory bowel disease and autism, and in fact, there is evidence that a subset of autistic children experience gastrointestinal abnormalities, which could be indicative of a decrease in mucosal integrity (Levy et al., 2007; de Magistris et al., 2010).”
BackgroundMicrobiome and nutrition in autism spectrum disorder: Current knowledge and research needs
Berding, K., & Donovan, S. M. (2016) · Nutrition Reviews · doi:10.1093/nutrit/nuw048 · Cited by 146
Nutritional interventions for autism spectrum disorder
Karhu, E., Zukerman, R. J., Eshraghi, R. S., Mittal, J., Deth, R. C., Castejon, A. M., Trivedi, M. S., Mittal, R., & Eshraghi, A. A. (2019) · Nutrition Reviews · doi:10.1093/nutrit/nuz092 · Cited by 182
“seen in patients with ASD along with comorbid GI symptoms.(11,16,17,21,22) Interestingly, gluten sensitivity has been implicated with other neuropsychiatric conditions, including schizophrenia, ataxia, and attentiondeficit/hyperactivity disorder.”
BackgroundMethodInfant microbes and metabolites point to childhood neurodevelopmental disorders
Ahrens, A. P., Hyötyläinen, T., Petrone, J. R., Igelström, K. M., George, C. D., Garrett, T. J., Orešič, M., Triplett, E. W., & Ludvigsson, J. (2024) · Cell · doi:10.1016/j.cell.2024.02.035 · Cited by 166
“Our study emphasizes the need for further research on dysbiosis persistence and functional consequences across early childhood, crucial for developing optimal interventions and understanding causality.”
BackgroundRisk Factors for Unhealthy Weight Gain and Obesity among Children with Autism Spectrum Disorder
Dhaliwal, K. K., Orsso, C. E., Richard, C., Haqq, A. M., & Zwaigenbaum, L. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133285 · Cited by 173
“Specifically, children with ASD exhibited greater gut permeability than TD children, as assessed by zonulin concentrations [164] or sugar probes (lactulose and mannitol) [165].”
BackgroundAutism and nutrition: the role of the gut–brain axis
Sande, M. M. H. V. D., van Buul, V. J., & Brouns, F. J. P. H. (2014) · Nutrition Research Reviews · doi:10.1017/s0954422414000110 · Cited by 186
“Two studies (28,41) found an abnormally high intestinal permeability in autistic children, compared with normal controls.”
InfluentialAdams, J. B., AUDHYA, T. K., McDonough-Means, S. I., Rubin, R. A., Quig, D. W., Geis, E., Gehn, E., Loresto, M., Mitchell, J., Atwood, S., et al. (2012) · Biological Trace Element Research · doi:10.1007/s12011-012-9551-1 · Cited by 148
“The reason for the higher body burden of toxic metals may relate to increased exposure to toxic metals, increased absorption due to intestinal permeability [39] and/or decreased ability to excrete toxic metals (due to low glutathione and abnormal gut bacteria due to increased oral antibiotic use).”
BackgroundThe mind-body-microbial continuum
Gonzalez, A., Stombaugh, J., Lozupone, C., Turnbaugh, P. J., Gordon, J. I., & Knight, R. D. (2011) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2011.13.1/agonzalez · Cited by 159
“Abnormally high intestinal permeability (IPT), or a “leaky gut,” has also been associated with autism, suggesting that autistic individuals may have increased sensitivity to components of our diet and their metabolites, because they can more easily access the bloodstream.(56) Autistic individuals on a GF/CF diet had s…”
Gabriele, S., Sacco, R., Cerullo, S., Neri, C., Urbani, A., Tripi, G., Malvy, J., Barthélémy, C., Bonnet‐Brilhault, F., & Persico, A. M. (2014) · Biomarkers · doi:10.3109/1354750x.2014.936911 · Cited by 137
“…because ASD has been associated with enhanced frequencies of (1) excessive gut permeability, reported by at least some (D’Eufemia et al., 1996; De Magistris et al., 2010), though not all studies (Robertson et al., 2008) and (2) gut infection with cresolproducing C. difficile (Finegold et al.,…”
BackgroundMarkers of celiac disease and gluten sensitivity in children with autism
Lau, N. M., Green, P. H. R., Taylor, A. K., Hellberg, D., Ajamian, M., Tan, C. Z., Kosofsky, B. E., Higgins, J. J., Rajadhyaksha, A. M., & Alaedini, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066155 · Cited by 124
Gut barrier in health and disease: focus on childhood.
Viggiano, D. P. P. D. O., Ianiro, G., Vanella, G., Bibbò, S., Bruno, G., Simeone, G., & Mele, G. (2015) · PubMed · Cited by 162
Revisiting the role of Akkermansia muciniphila as a therapeutic bacterium
Si, J., Kang, H., You, H. J., & Ko, G. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2078619 · Cited by 138
“Although relevant mechanistic studies have yet to be undertaken, it is possible that Akkermansia may ameliorate the increased gut permeability seen in ASD patients.(59) A.”
BackgroundBested, A. C., Logan, A. C., & Selhub, E. M. (2013) · Gut Pathogens · doi:10.1186/1757-4749-5-3 · Cited by 121
“8% in healthy controls) [54].”
Lefter, R., Ciobica, A., Timofte, D., Stanciu, C., & Trifan, A. (2019) · Medicina · doi:10.3390/medicina56010011 · Cited by 120
“Gluten-casein-free diet were signaled to significantly lower the abnormal high intestinal permeability values in subgroups of ASD patients [55] and even resolve the GI symptoms and progressively ameliorate ASD symptoms in a clinical case diagnosed with severe autism [56].”
BackgroundGut Microbiota, Inflammation, and Probiotics on Neural Development in Autism Spectrum Disorder
Doenyas, C. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.01.060 · Cited by 130
Bundgaard‐Nielsen, C., Knudsen, J. K., Leutscher, P. D. C., Lauritsen, M. B., Nyegaard, M., Hagstrøm, S., & Sørensen, S. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1748258 · Cited by 137
Butwicka, A., Olén, O., Larsson, H., Halfvarson, J., Almqvist, C., Lichtenstein, P., Serlachius, E., Frisén, L., & Ludvigsson, J. F. (2019) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2019.2662 · Cited by 117
Metadata
- Authors
- de Magistris, L., Familiari, V., Pascotto, A., Sapone, A., Frolli, A., Iardino, P., Carteni, M., De Rosa, M., Francavilla, R., Riegler, G., Militerni, R., & Bravaccio, C.
- Affiliations
- Department Magrassi‐Lanzara Gastroenterology Italy
- Department of Psychiatry, Neuropsychiatry, Dermatovenereology Italy
- University of Campania "Luigi Vanvitelli" (IT)
- Department of Experimental Medicine Italy
- University of Bari Aldo Moro (IT)
- Federico II University Hospital (IT)
- Corresponding author
- de Magistris, Laura
- Familiari, Valeria
- Sapone, Anna
- Riegler, Gabriele
- Venue
- Journal of Pediatric Gastroenterology and Nutrition
- Publisher
- Wiley
- Published
- 2010-10
- Volume
- 51
- Issue
- 4
- Pages
- 418-424
- ISSN
- 0277-2116 (ISSN-L)
- 1536-4801
- OpenAlex
- W2046831320
- Cited by
- 546
- References
- 55
- Citations by year
- 2026: 18 · 2025: 33 · 2024: 31 · 2023: 31 · 2022: 36 · 2021: 58 · 2020: 48 · 2019: 43 · 2018: 49 · 2017: 28 · 2016: 36 · 2015: 30 · 2014: 28 · 2013: 35 · 2012: 27
- FWCI
- 14.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Pediatric Gastroenterology and Nutrition (publishedVersion)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Psychiatry and Mental health › Child Nutrition and Feeding Issues
- Keywords
- autism spectrum disorder, intestinal permeability, fecal calprotectin, lactulose/mannitol test, gluten-free diet, gastrointestinal symptoms, constipation, diarrhea, first-degree relatives, tight junctions
- MeSH terms
- Analysis of Variance, Child, Child Development Disorders, Pervasive, Constipation, Diarrhea, Enzyme-Linked Immunosorbent Assay, Family, Feces, Female, Humans, Inflammation, Intestinal Diseases, Intestinal Mucosa, Italy, Male, Permeability, Abdominal Pain, Comorbidity, Leukocyte L1 Antigen Complex
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.